Business Description

Description
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 0.53
Equity-to-Asset 0.47
Debt-to-Equity 0.57
Debt-to-EBITDA 1.35
Interest Coverage 11.59
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.24
Distress
Grey
Safe
Beneish M-Score -2.61
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.16
Quick Ratio 0.93
Cash Ratio 0.53
Days Inventory 177.66
Days Sales Outstanding 57.86
Days Payable 125.99

Financials (Next Earnings Date:2024-04-23)

LSE:0HKE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Novartis AG Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 40,994.08
EPS (TTM) (£) 0
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (£) 0
20-Day SMA (£) 0
12-1 Month Momentum % 0
52-Week Range (£) 66.3 - 3657.04
Shares Outstanding (Mil) 2,420.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novartis AG Filings

Filing Date Document Date Form
No Filing Data

Novartis AG Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Novartis AG Frequently Asked Questions

What is Novartis AG(LSE:0HKE)'s stock price today?
The current price of LSE:0HKE is £3657.04. The 52 week high of LSE:0HKE is £3657.04 and 52 week low is £66.30.
When is next earnings date of Novartis AG(LSE:0HKE)?
The next earnings date of Novartis AG(LSE:0HKE) is 2024-04-23.
Does Novartis AG(LSE:0HKE) pay dividends? If so, how much?
The  Dividend Yield %  of Novartis AG(LSE:0HKE) is 4.26% (As of Today), Highest Dividend Payout Ratio of Novartis AG(LSE:0HKE) was 1.19. The lowest was 0.33. And the median was 0.85. The  Forward Dividend Yield % of Novartis AG(LSE:0HKE) is 0%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release